HNGE Company Profile and Key Details

HNGE has shown weak momentum, losing -14.13% over the past week and -15.54% over the past quarter, though year-to-date performance is down -10.4%. Short-term trend indicators are bullishly aligned (SMA20 17.41%, SMA50 3.1%, SMA200 -7.11%). The stock’s 14-day RSI is 60.61 (firm momentum), while the ATR of 2.48 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -29.77% below its high and over 45.18% above its low. Average 10-day trading volume of 1.69 million shares is below the 3-month average of 1.91 million, indicating normal recent market interest.

Hinge Health, Inc. has 62.47 million shares outstanding. The public float is 49.52 million shares, elevated short interest at 9.67% of float. This equals 5.96 million shares. The short ratio is 3.78 days. Institutional investors hold 115.84% of the float. Insiders own 5.81%. Bessemer Venture Partners X L.P. holds 3.38 million shares, Pursley James has 706.24 thousand shares and Budge James has 445.39 thousand shares. Over the past six months, insider transactions show net selling. They sold 302.27 thousand shares across 32 transactions.

Hinge Health, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $22.57. This means the shares are trading above this model’s fair value.

Wall Street analysts project EPS growth of 1.95% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 32 Strong Buy ratings, 16 Buy ratings, 1 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $125.00 to $45.00. The high target offers 41.1% upside. The low target suggests -49.2% downside. The mean target is $77.67. This offers -12.33% upside. Hinge Health, Inc. earnings surprise history is a mixed track record. The quarter that ended August 04, 2026, missed forecasts by -4.07%. The prior quarter beat by 15.38%. Over the last six quarters, Apple has recorded several small beats. These include 644.44% in August 05, 2025.

Hinge Health, Inc. trades at a P/E ratio of 65.79, slightly above the S&P 500 average, with a price-to-sales ratio of 9.52 and a price-to-book ratio of 20.27 reflecting a rich premium to book value. The P/FCF stands at 23.86, also above market averages. Compared to sector medians, Hinge Health, Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Hinge Health, Inc. (NYSE:HNGE) closed at $88.59 USD, gaining $0.33 (0.37%) from the previous close of $88.26. The stock is currently mid-range between its 52-week high and low $30.08 and $95.57. With a market capitalization of about $6.86 billion, Hinge Health, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~1.36). Key stats such as the average daily volume over the past year has been around 1.96 million shares, in line with its 52-week average. Headquartered in San Francisco, CA, Hinge Health, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Daniel A. Perez, the company employs approximately 1,437 people and listed since May 22, 2025. Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health.

Our AI price prediction model suggests that Hinge Health, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 3.58%, with price expected at $91.76 by September 25, 2026, within a range of $88.98 to $94.25 3-Month Outlook: Projected fall of -13.5%, reaching $76.63 by December 10, 2026, with a range of $75.60 to $77.73. 1-Year Outlook: Projected gain of 42.58%, with price at $126.31 by September 10, 2027, within a range of $121.57 to $130.13.

Hinge Health, Inc. (NYSE:HNGE) shares are down -10.4% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Hinge Health, Inc. trading at a premium to the broader market with a P/E of 65.79. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $69.62, suggesting -21.41% downside. Our AI forecast model points to short-term strength (3.58% over two weeks), a medium-term fall (-13.5% over three months), and a longer-term gain (42.58% over one year), with expected trading ranges indicating moderate volatility.